These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7152170)

  • 1. Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells.
    Atsumi T; Shirayoshi Y; Takeichi M; Okada TS
    Differentiation; 1982; 23(1):83-6. PubMed ID: 7152170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrids between F9 nullipotent teratocarcinoma and thymus cells produce multidifferentiated tumors in mice.
    Rousset JP; Bucchini D; Jami J
    Dev Biol; 1983 Apr; 96(2):331-6. PubMed ID: 6832476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hybrids between F9 "nullipotent" teratocarcinoma and rat thymus cells produce differentiated cells].
    Hsu WM; Song QB; Yao Z
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):177-87. PubMed ID: 3835750
    [No Abstract]   [Full Text] [Related]  

  • 4. Pluripotent teratocarcinoma-thymus somatic cell hybrids.
    Miller RA; Ruddle FH
    Cell; 1976 Sep; 9(1):45-55. PubMed ID: 61820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine embryonal carcinoma hybrids: decreased ability to spontaneously differentiate as a dominant trait.
    Oshima RG; McKerrow J; Cox D
    J Cell Physiol; 1981 Nov; 109(2):195-204. PubMed ID: 7197684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotency of somatic cell hybrids between nullipotent and pluripotent embryonal carcinoma cells.
    Rosenstraus MJ; Balint RF; Levine AJ
    Somatic Cell Genet; 1980 Jul; 6(4):555-65. PubMed ID: 7444716
    [No Abstract]   [Full Text] [Related]  

  • 7. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A malignant, stem cell-like somatic hybrid between a mouse teratocarcinoma and a rat ascitic hepatoma is differentiation competent.
    Subramanian V
    Cell Differ Dev; 1989 Sep; 27(3):197-214. PubMed ID: 2478269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cellular oncogenes in teratoma-derived cell lines.
    Sejersen T; Sümegi J; Ringertz NR
    Exp Cell Res; 1985 Sep; 160(1):19-30. PubMed ID: 2412863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous differentiation in the colonies of a nullipotent embryonal carcinoma cell line (F9).
    Zákány J; Burg K; Raskó I
    Differentiation; 1984; 27(2):146-51. PubMed ID: 6479493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonal carcinoma cells (and their somatic cell hybrids) are resistant to infection by the murine parvovirus MVM, which does infect other teratocarcinoma-derived cell lines.
    Miller RA; Ward DC; Ruddle FH
    J Cell Physiol; 1977 Jun; 91(3):393-401. PubMed ID: 558990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the developmental potential of embryonal carcinoma cells in mixed aggregates of nullipotent and pluripotent cells.
    Rosenstraus MJ; Levine AJ
    Cell; 1979 Jun; 17(2):337-46. PubMed ID: 455469
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of X-inactivation in female mouse somatic cells hybridized with murine teratocarcinoma stem cells in vitro.
    Takagi N; Yoshida MA; Sugawara O; Sasaki M
    Cell; 1983 Oct; 34(3):1053-62. PubMed ID: 6627391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic hybrid cells: a powerful tool for studying pluripotency and reprogramming of the differentiated cell chromosomes.
    Serov O; Matveeva N; Kuznetsov S; Kaftanovskaya E; Mittmann J
    An Acad Bras Cienc; 2001 Dec; 73(4):561-8. PubMed ID: 11743603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells.
    Litwack G; Croce CM
    J Cell Physiol; 1979 Oct; 101(1):1-8. PubMed ID: 44296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and differentiation of embryonal carcinoma cell line F9 in defined media.
    Rizzino A; Crowley C
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):457-61. PubMed ID: 6244561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal lines of teratocarcinoma cells in vitro: differentiation and cytogenetic characteristics.
    McBurney MW
    J Cell Physiol; 1976 Nov; 89(3):441-55. PubMed ID: 988033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The F9-EC cell line as a model for the analysis of differentiation.
    Alonso A; Breuer B; Steuer B; Fischer J
    Int J Dev Biol; 1991 Dec; 35(4):389-97. PubMed ID: 1666294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic cooperation between mouse embryonal carcinoma cells and their differentiated derivatives.
    Nicolas JF; Jakob H; Jacob F
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3292-6. PubMed ID: 277927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental potentialities and surface antigens of mouse teratocarcinoma x lymphoid cell hybrids.
    Rousset JP; Jami J; Dubois P; Avilès D; Ritz E
    Somatic Cell Genet; 1980 May; 6(3):419-33. PubMed ID: 7404272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.